We assign a fundamental rating of 1 out of 10 to BHVN. BHVN was compared to 525 industry peers in the Biotechnology industry. BHVN may be in some trouble as it scores bad on both profitability and health. BHVN has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

BHVN had negative earnings in the past year.
BHVN had a negative operating cash flow in the past year.
In the past 5 years BHVN always reported negative net income.
In the past 5 years BHVN always reported negative operating cash flow.

1.2 Ratios

BHVN has a Return On Assets of -190.68%. This is amonst the worse of the industry: BHVN underperforms 87.24% of its industry peers.

		Industry Rank	Sector Rank
ROA	-190.68%
ROE	N/A
ROIC	N/A

ROA(3y)-101.1%

ROA(5y)-112.04%

ROE(3y)-133.7%

ROE(5y)-344.72%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

BHVN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

BHVN has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BHVN has been increased compared to 5 years ago.
There is no outstanding debt for BHVN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

BHVN has an Altman-Z score of -9.84. This is a bad value and indicates that BHVN is not financially healthy and even has some risk of bankruptcy.
BHVN has a Altman-Z score of -9.84. This is in the lower half of the industry: BHVN underperforms 72.00% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-9.84

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 2.86 indicates that BHVN has no problem at all paying its short term obligations.
BHVN has a Current ratio of 2.86. This is in the lower half of the industry: BHVN underperforms 66.10% of its industry peers.
BHVN has a Quick Ratio of 2.86. This indicates that BHVN is financially healthy and has no problem in meeting its short term obligations.
BHVN has a worse Quick ratio (2.86) than 64.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.86
Quick Ratio	2.86

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

BHVN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.72%, which is quite good.

EPS 1Y (TTM)18.72%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%3.53%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, BHVN will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.83% on average per year.
BHVN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 134.42% yearly.

EPS Next Y27.92%

EPS Next 2Y27.35%

EPS Next 3Y19.75%

EPS Next 5Y14.83%

Revenue Next Year-100%

Revenue Next 2Y68.37%

Revenue Next 3Y156.72%

Revenue Next 5Y134.42%

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BHVN. In the last year negative earnings were reported.
Also next year BHVN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.